Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Integra Lifesciences Holdings Corp as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 282
- +2 vs. Q2 2022
- Shares held
- 73.8M
- +710.2K (+1.0%) vs. Q2 2022
- Total value
- $3.13B
- −$824.9M (−20.9%) vs. Q2 2022
- New holders
- 37
- 131 more added
- Sold out
- 35
- 73 more reduced
5 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IART on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $1.32B |
| Q1 2026 | 202 | $704.7M |
| Q4 2025 | 205 | $919.4M |
| Q3 2025 | 207 | $1.04B |
| Q2 2025 | 209 | $896.9M |
| Q1 2025 | 220 | $1.62B |
| Q4 2024 | 223 | $1.57B |
| Q3 2024 | 225 | $1.24B |
| Q2 2024 | 238 | $2.07B |
| Q1 2024 | 281 | $2.34B |
| Q4 2023 | 284 | $2.92B |
| Q3 2023 | 263 | $2.63B |
| Q2 2023 | 283 | $2.85B |
| Q1 2023 | 280 | $4.18B |
| Q4 2022 | 281 | $4.20B |
| Q3 2022 | 282 | $3.13B |
| Q2 2022 | 285 | $3.95B |
| Q1 2022 | 278 | $4.80B |
| Q4 2021 | 277 | $5.19B |
| Q3 2021 | 262 | $5.27B |
| Q2 2021 | 264 | $5.10B |
| Q1 2021 | 257 | $5.10B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Integra Lifesciences Holdings Corp; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −4,698−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −4,567−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −4,320−100.0% | Sold out |
| Burney Co | 0 | $0 | 0.00% | −4,070−100.0% | Sold out |
| Stanley-Laman Group, Ltd. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Shelton Capital Management | 0 | $0 | 0.00% | −3,953−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −2,767−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −476−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −296−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −221−100.0% | Sold out |
| TD Ameritrade Investment Management, LLC | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| WFA of San Diego, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Sciencast Management LP | – | – | – | – | Not filed |
| Loveless Wealth Management LLC | – | – | – | – | Not filed |
| Private Capital Group, LLC | – | – | – | – | Not filed |
| Lake Point Wealth Management | – | – | – | – | Not filed |
| Fieldpoint Private Securities, LLC | – | – | – | – | Not filed |